Feed Preview

Fast Growing

Postpoliomyelitis Syndrome

Postpoliomyelitis Syndrome diagram by Sebastian Kaulitzki, Shutterstock
Sebastian Kaulitzki, Shutterstock

Postpoliomyelitis syndrome is characterized by a sudden or progressive loss of muscle strength, muscle atrophy, muscle pain, fatigue, intolerance to cold, after a period of at least 15 years from the acute polio virus infection, a period of neurological and functional stability. Here is the latest research.

Top 20 most recent papers
Neuro-degenerative Diseases

Effects of Sleep-Related Disorders on the Prognosis of Amyotrophic Lateral Sclerosis

Neuro-degenerative DiseasesMarch 3, 2020
Aylin ReyhaniDerya Karadeniz
2
1
JAMA : the Journal of the American Medical Association

Poliovirus Type 3 Is Eradicated

JAMA : the Journal of the American Medical AssociationDecember 18, 2019
Bridget Kuehn
46
2
1
Communicable Diseases Intelligence

Acute flaccid myelitis - has it gone unrecognised in Australian children?

Communicable Diseases IntelligenceMarch 18, 2020
Junchao BaoPhillip N Britton
1
Emerging Microbes & Infections

Tropism, pathology, and transmission of equine parvovirus-hepatitis

Emerging Microbes & InfectionsMarch 21, 2020
J TomlinsonG R Van de Walle
1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

Waning vaccine immunity and vaccination responses in children treated for acute lymphoblastic leukemia: A Canadian Immunization Research Network Study

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of AmericaFebruary 19, 2020
Karina A TopScott A Halperin
Sultan Qaboos University Medical Journal

Wild Poliovirus Type 1 in Oman: A re-emerging threat that requires urgent, targeted and strategic preparedness

Sultan Qaboos University Medical JournalMarch 20, 2020
Salah T Al Awaidy, Faryal Khamis
1
The Pan African Medical Journal

Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria

The Pan African Medical JournalMarch 12, 2020
Fwangshak Ayuba LengkatOnyedibe Kenneth
1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

Reliability and validity of speech & pause measures during passage reading in ALS

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationMarch 7, 2020
Carolina BarnettYana Yunusova
2
1
Risk Analysis : an Official Publication of the Society for Risk Analysis

Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame

Risk Analysis : an Official Publication of the Society for Risk AnalysisJanuary 22, 2020
Dominika A KalkowskaKimberly M Thompson
2
Cutis

Kaposi sarcoma in a patient with postpolio syndrome

CutisDecember 31, 2019
Melodi Javid WhitleyDavid G Kirsch
Mediators of Inflammation

Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines

Mediators of InflammationFebruary 25, 2020
Weijian ZhangJincheng Zeng
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/postpoliomyelitis-syndrome/2ea118b7-7ce2-4613-a09e-d2f601a3a256